Proprietary AI analyst is now available

Ingevity Valuation Multiples

Discover Ingevity's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Quaker Houghton, Orbia, OQ Base Industries, Hexpol and more.

Ingevity Overview

About Ingevity

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.


Founded

2015

HQ

United States

Employees

1.7K

Sectors

Financials (LTM)

Revenue: $1B
EBITDA: $389M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ingevity Financials

Ingevity reported last 12-month revenue of $1B and EBITDA of $389M.

In the same LTM period, Ingevity generated $448M in gross profit, $389M in EBITDA, and had net loss of ($19M).

Revenue (LTM)


Ingevity P&L

In the most recent fiscal year, Ingevity reported revenue of $1B and EBITDA of $398M.

Ingevity is unprofitable as of last fiscal year, with gross margin of 40%, EBITDA margin of 34%, and net margin of (14%).

See analyst estimates for Ingevity
LTMLast FY202320242025202620272028
Revenue$1B$1B$2B$1B$1B
Gross Profit$448M$462M$472M$455M$462M
Gross Margin39%40%28%32%40%
EBITDA$389M$398M$206M($330M)$41M
EBITDA Margin34%34%12%(23%)4%
EBIT Margin25%25%15%18%22%
Net Profit($19M)($167M)($5M)($430M)($167M)
Net Margin(2%)(14%)(0%)(31%)(14%)
Net Debt-$1B---

Financial data powered by Morningstar, Inc.

Ingevity Stock Performance

Ingevity has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Ingevity's stock price is $71.98.

Ingevity share price increased by 6.1% in the last 30 days, and by 67.0% in the last year.

Ingevity has an EPS (earnings per share) of $-4.81.

See more trading valuation data for Ingevity
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B0.0%6.1%1.1%67.0%$-4.81

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ingevity Valuation Multiples

Ingevity trades at 3.2x EV/Revenue multiple, and 9.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Ingevity

EV / Revenue (LTM)


Ingevity Financial Valuation Multiples

As of June 15, 2026, Ingevity has market cap of $3B and EV of $4B.

Ingevity has a P/E ratio of (130.6x).

LTMLast FY202320242025202620272028
EV/Revenue3.2x3.1x2.2x2.6x3.1x
EV/EBITDA9.4x9.2x17.7x(11.1x)88.2x
EV/EBIT12.7x12.6x14.2x14.1x13.9x
EV/Gross Profit8.1x7.9x7.7x8.0x7.9x
P/E(130.6x)(15.0x)n/m(5.8x)(15.0x)
EV/FCF14.2x13.4x38.3x71.6x13.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ingevity Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ingevity Margins & Growth Rates

Ingevity decreased revenue by 6% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, Ingevity reported gross margin of 40%, EBITDA margin of 34%, and net margin of (14%).

See estimated margins and future growth rates for Ingevity

Ingevity Margins

Last FY202420252026202720282029
Gross Margin40%32%40%44%
EBITDA Margin34%(23%)4%34%
EBIT Margin25%18%22%26%
Net Margin(14%)(31%)(14%)14%
FCF Margin23%4%23%22%

Ingevity Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(6%)(17%)(17%)(6%)
Gross Profit Growth4%(4%)1%4%
EBITDA Growth(5%)(260%)(113%)814%
EBIT Growth(2%)1%1%8%
Net Profit Growth(195%)7869%(61%)(195%)
FCF Growth(14%)(46%)436%(14%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ingevity Operational KPIs

Ingevity's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.1M for the same period.

Ingevity's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Ingevity's Rule of X is 20% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Ingevity
LTMLast FY202320242025202620272028
Rule of 4030%29%---
Bessemer Rule of X24%20%---
Revenue per Employee-$0.7M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue-2%2%2%2%
Opex to Revenue-17%13%14%17%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ingevity Competitors

Ingevity competitors include Quaker Houghton, Orbia, OQ Base Industries, Hexpol, Saudi Industrial Investment Group, Verbio, Zeon, Saudi Kayan, Huntsman and Sipchem.

Most Ingevity public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Quaker Houghton1.7x1.7x10.8x10.8x
Orbia1.0x0.9x6.6x6.2x
OQ Base Industries4.8x4.5x10.8x11.0x
Hexpol1.3x1.4x7.5x7.8x
Saudi Industrial Investment Group--(133.6x)282.6x
Verbio1.4x1.2x141.2x14.1x
Zeon1.0x1.0x8.0x7.7x
Saudi Kayan2.1x2.0x23.7x17.0x

This data is available for Pro users. Sign up to see all Ingevity competitors and their valuation data.

Start Free Trial

Acquisitions by Ingevity

Ingevity has acquired 2 companies to date.

Last acquisition by Ingevity was on August 2nd 2022. Ingevity acquired Ozark Materials for $325M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Ingevity

Ozark Materials
Georgia-Pacific (Pine Chemicals unit)
Description
Ozark Materials is a Springfield-headquartered manufacturer of pavement marking materials including thermoplastic compounds, paints, and glass beads for roadway striping and signage. Products support highway lane markings, airport runways, and municipal streets, distributed nationwide through depots in Missouri, Texas, and California. Primary customers encompass state departments of transportation such as Missouri DOT, highway contractors like Millers Mutual Group, county governments, universities, and airport authorities. The firm maintains ISO-certified production facilities producing over 50 formulations tailored to MUTCD standards.
Georgia-Pacific's Pine Chemicals unit produces specialty resins, tall oil fatty acids, rosin derivatives, and polyterpenes from kraft pine byproducts at plants in Savannah, Georgia, and Cedar Springs. It supplies adhesives, inks, coatings, and rubber industries worldwide, marketing under brands like G-P Pine Chemicals for global manufacturers.
HQ CountryUnited StatesUnited States
HQ City
Greenville, SC
Atlanta, GA
Deal Date2 Aug 202222 Aug 2017
Valuation$325M$310M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ingevity acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Ingevity

Ingevity has invested in 2 companies to date.

Latest investment by Ingevity was on August 3rd 2022. Ingevity invested in Nexeon in their $50M Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Ingevity

Nexeon
Mito Material Solutions
Description
Nexeon is an Oxfordshire-headquartered developer and manufacturer of silicon-based anode materials for lithium-ion batteries. Its products enable higher energy density in cells for electric vehicles and consumer electronics. Nexeon operates production facilities in the United Kingdom and Japan, supplying battery makers worldwide. The company advances patented silicon anode technology to support extended range and faster charging in EV applications.
Mito Material Solutions is a materials science company offering the MITO T-Series nano-additive for epoxy and resin composites. This additive doubles toughness in composite parts and reduces mechanical failure risk by 80 percent, enabling options like 100 percent toughness increase or 35 percent material reduction. Applications span recreational vehicles for fiberglass shells, boating for hulls, and aerospace for weight savings of tens of thousands of pounds per aircraft. Headquartered in the United States, the company targets manufacturers seeking lighter, stronger components to cut costs and improve performance.
HQ CountryUnited KingdomUnited States
HQ City
Aberdeen
Indianapolis, IN
Deal Date3 Aug 20228 Mar 2022
RoundStrategic investmentSeed
Raised$50M$5M
InvestorsIngevityIngevity
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Ingevity investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ingevity

When was Ingevity founded?Ingevity was founded in 2015.
Where is Ingevity headquartered?Ingevity is headquartered in United States.
How many employees does Ingevity have?As of today, Ingevity has over 1K employees.
Who is the CEO of Ingevity?Ingevity's CEO is David H. Li.
Is Ingevity publicly listed?Yes, Ingevity is a public company listed on NYSE.
What is the stock symbol of Ingevity?Ingevity trades under NGVT ticker.
When did Ingevity go public?Ingevity went public in 2016.
Who are competitors of Ingevity?Ingevity main competitors include Quaker Houghton, Orbia, OQ Base Industries, Hexpol, Saudi Industrial Investment Group, Verbio, Zeon, Saudi Kayan, Huntsman, Sipchem.
What is the current market cap of Ingevity?Ingevity's current market cap is $3B.
What is the current revenue of Ingevity?Ingevity's last 12 months revenue is $1B.
What is the current revenue growth of Ingevity?Ingevity revenue growth (NTM/LTM) is (4%).
What is the current EV/Revenue multiple of Ingevity?Current revenue multiple of Ingevity is 3.2x.
What is the current EBITDA of Ingevity?Ingevity's last 12 months EBITDA is $389M.
What is Ingevity's EBITDA margin?Ingevity's last 12 months EBITDA margin is 34%.
What is the current EV/EBITDA multiple of Ingevity?Current EBITDA multiple of Ingevity is 9.4x.
What is the current FCF of Ingevity?Ingevity's last 12 months FCF is $257M.
What is Ingevity's FCF margin?Ingevity's last 12 months FCF margin is 23%.
What is the current EV/FCF multiple of Ingevity?Current FCF multiple of Ingevity is 14.2x.
How many companies Ingevity has acquired to date?As of June 2026, Ingevity has acquired 2 companies.
What was the largest acquisition by Ingevity?$325M acquisition of Ozark Materials on 2nd August 2022 was the largest M&A Ingevity has done to date.
In how many companies Ingevity has invested to date?As of June 2026, Ingevity has invested in 2 companies.
What was the last Ingevity investment?On 3rd August 2022 Ingevity invested in Nexeon, participating in a $50M Strategic investment round.
In what companies Ingevity invested in?Ingevity invested in Nexeon and Mito Material Solutions.

See public comps similar to Ingevity

Lists including Ingevity

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial